Literature DB >> 25661569

Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS Substudy).

Liang Dong1, Gary S Mintz2, Bernhard Witzenbichler3, D Christopher Metzger4, Michael J Rinaldi5, Peter L Duffy6, Giora Weisz7, Thomas D Stuckey8, Bruce R Brodie8, Kyeong Ho Yun9, Ke Xu2, Ajay J Kirtane10, Gregg W Stone10, Akiko Maehara11.   

Abstract

Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents (ADAPT-DES) was a prospective, multicenter registry of 8,582 consecutive stable and unstable patients who underwent percutaneous coronary intervention using a drug-eluting stent. We sought to identify key morphologic features leading to ST-segment elevation myocardial infarction (STEMI) versus non-STEMI (NSTEMI) or unstable angina pectoris (UA) versus stable coronary artery disease (CAD) presentation. In the prespecified grayscale and virtual histology (VH) substudy of ADAPT-DES, preintervention imaging identified 676 patients with a single culprit lesion. The relation between lesion morphology and clinical presentation was compared among patients with (1) STEMI, (2) NSTEMI or UA, and (3) stable CAD. Intravascular ultrasound identified more plaque rupture and VH thin-cap fibroatheroma (TCFA) in STEMI lesions compared with NSTEMI/UA or stable CAD lesions; conversely, fibroatheromas appeared more often calcified with a thick fibrous cap in stable CAD. Minimum lumen cross-sectional area (MLA) was smaller with larger plaque burden and positive remodeling in STEMI lesions. Lesions with plaque rupture versus those without plaque rupture showed higher prevalence of VH-TCFA and larger plaque burden with positive remodeling, especially in patients with STEMI. Multivariate analysis showed that in the lesions with plaque rupture, plaque burden at the MLA site was the only independent predictor for STEMI (cutoff of plaque burden = 85%) and in lesions without plaque rupture, MLA was the only independent predictor for STEMI (cutoff of MLA = 2.3 mm(2)). In conclusion, culprit lesions causing STEMI have smaller lumen areas, greater plaque burden, and more plaque rupture or VH-TCFA compared with NSTEMI/UA or stable CAD; in lesions with plaque rupture, only plaque burden predicted STEMI, and in lesions without plaque rupture, only MLA area predicted STEMI.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25661569     DOI: 10.1016/j.amjcard.2015.01.008

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Gender differences in plaque characteristics of culprit lesions in patients with ST elevation myocardial infarction.

Authors:  Soe Hee Ann; Cai De Jin; Gillian Balbir Singh; Kyung Hun Lim; Jae-Wook Chung; Scot Garg; Moo Hyun Kim; Wang-Soo Lee; Kyoung Im Cho; Sang Wook Kim; Eun-Seok Shin
Journal:  Heart Vessels       Date:  2016-02-13       Impact factor: 2.037

2.  Impact of tissue protrusion after coronary stenting in patients with ST-segment elevation myocardial infarction.

Authors:  Yoshiyuki Okuya; Yuichi Saito; Yoshiaki Sakai; Iwao Ishibashi; Yoshio Kobayashi
Journal:  Int J Cardiovasc Imaging       Date:  2018-10-16       Impact factor: 2.357

3.  Elevated levels of sIL-2R, TNF-α and hs-CRP are independent risk factors for post percutaneous coronary intervention coronary slow flow in patients with non-ST segment elevation acute coronary syndrome.

Authors:  Cheng Wang; Yan Wu; Yang Su; Bin Mao; Yihong Luo; Yexiang Yan; Kun Hu; Yi Lu; Wenliang Che; Minying Wan
Journal:  Int J Cardiovasc Imaging       Date:  2022-02-19       Impact factor: 2.357

Review 4.  Exosomal Composition, Biogenesis and Profiling Using Point-of-Care Diagnostics-Implications for Cardiovascular Disease.

Authors:  Denise Burtenshaw; Brian Regan; Kathryn Owen; David Collins; David McEneaney; Ian L Megson; Eileen M Redmond; Paul Aidan Cahill
Journal:  Front Cell Dev Biol       Date:  2022-06-01

5.  Helicobacter pylori Seropositivity in Patients with Interleukin-1 Polymorphisms Is Significantly Associated with ST-Segment Elevation Myocardial Infarction.

Authors:  Noriaki Tabata; Daisuke Sueta; Tomonori Akasaka; Yuichiro Arima; Kenji Sakamoto; Eiichiro Yamamoto; Yasuhiro Izumiya; Megumi Yamamuro; Kenichi Tsujita; Sunao Kojima; Koichi Kaikita; Kazunori Morita; Kentaro Oniki; Junji Saruwatari; Kazuko Nakagawa; Seiji Hokimoto
Journal:  PLoS One       Date:  2016-11-10       Impact factor: 3.240

6.  Plaque Characteristics and Ruptured Plaque Location according to Lesion Geometry in Culprit Lesions of ST-Segment Elevation Myocardial Infarction.

Authors:  Ju Hyun Chung; Joo Myung Lee; Ae Young Her; Heeyoun Cho; Joon Hyung Doh; Chang Wook Nam; Hyung Il Kim; Bon Kwon Koo; Eun Seok Shin
Journal:  Korean Circ J       Date:  2017-10-26       Impact factor: 3.243

7.  Prognostic impact of alkaline phosphatase measured at time of presentation in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.

Authors:  Pyung Chun Oh; Kyounghoon Lee; Tae-Hoon Kim; Jeonggeun Moon; Hyun Woo Park; Ho-Jun Jang; Sang-Don Park; Sung Woo Kwon; Jon Suh; Woong Chol Kang
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

8.  Prevalence of lipid abnormalities and cholesterol target value attainment in Egyptian patients presenting with an acute coronary syndrome.

Authors:  Mohamed Sobhy; Adel El Etriby; Amany El Nashar; Sameh Wajih; Martin Horack; Philippe Brudi; Dominik Lautsch; Baishali Ambegaonkar; Ami Vyas; Anselm K Gitt
Journal:  Egypt Heart J       Date:  2018-08-22

9.  Dual antiplatelet therapy versus aspirin monotherapy in diabetics with stable ischemic heart disease undergoing coronary artery bypass grafting.

Authors:  Makoto Mori; Kayoko Shioda; Syed Usman Bin Mahmood; Abeel A Mangi; James J Yun; Arnar Geirsson
Journal:  Ann Cardiothorac Surg       Date:  2018-09

10.  Plasma neutrophil gelatinase-associated lipocalin levels are associated with the presence and severity of coronary heart disease.

Authors:  Chao Li; Zheng Zhang; Yu Peng; Hanxiang Gao; Yongxiang Wang; Jing Zhao; Chenliang Pan
Journal:  PLoS One       Date:  2019-08-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.